Positive correlation between variants of lipid metabolism-related genes and coronary heart disease

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 260-266

  Zhang, Li Na ^a   Liu, Pan Pan ^a   Zhou, Jianqing ^a   Huang, R Stephanie ^b   Yuan, Fang ^a   Fei, Li Juan ^a   Huang, Yi ^a   Xu, Limin ^a   Hao, Ling Mei ^c   Qiu, Xu Jun ^c   Le, Yanping ^a   Yang, Xi ^a   Xu, Weifeng ^a   Huang, Xiaoyan ^a   Ye, Meng ^a   Lian, Jiangfang ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c Seventh Hospital of Ningbo   (China)

Author keywords

APOB; Coronary heart disease; LIPA; LPA; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN B;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOMINANT INHERITANCE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

AGED; ALLELES; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 84878907222     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1454     Document Type: Article

References (41)

1. Yu J, Huang J, Liang Y, et al: Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China. Lipids Health Dis 10: 200, 2011.
2. Sandhu MS, Waterworth DM, Debenham SL, et al: LDL-cholesterol concentrations: a genome-wide association study. Lancet 371: 483-491, 2008. (Pubitemid 351199866)
3. Baigent C, Keech A, Kearney PM, et al: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278, 2005.
4. Willer CJ, Sanna S, Jackson AU, et al: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169, 2008. (Pubitemid 351171403)
5. Lettre G, Palmer CD, Young T, et al: Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet 7: e1001300, 2011.
6. St-Pierre AC, Cantin B, Dagenais GR, et al: Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. Am J Cardiol 97: 997-1001, 2006.
7. Moss AJ, Goldstein RE, Marder VJ, et al: Thrombogenic factors and recurrent coronary events. Circulation 99: 2517-2522, 1999. (Pubitemid 29228281)
8. Talmud PJ, Hawe E, Miller GJ and Humphries SE: Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 22: 1918-1923, 2002. (Pubitemid 35315782)
9. Walldius G and Jungner I: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 259: 493-519, 2006.
10. Kamstrup PR, Tybjærg-Hansen A and Nordestgaard BG: Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis. Arterioscler Thromb Vasc Biol 32: 1732-1741, 2012.
11. Szilágyi S, Péter A, Magyar MT, et al: Recurrent arterial thrombosis associated with the antithrombin basel variant and elevated lipoprotein(a) plasma level in an adolescent patient. J Pediatr Hematol Oncol 34: 276-279, 2012.
12. Terres W, Tatsis E, Pfalzer B, et al: Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 91: 948-950, 1995.
13. Deshmukh HA, Colhoun HM, Johnson T, et al: Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a). J Lipid Res 53: 1000-1011, 2012.
14. Teslovich TM, Musunuru K, Smith AV, et al: Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713, 2010.
15. Trégouët DA, König IR, Erdmann J, et al: Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 41: 283-285, 2009.
16. Qi L, Ma J, Qi Q, et al: Genetic risk score and risk of myocardial infarction in Hispanics. Circulation 123: 374-380, 2011.
17. Butterworth AS, Braund PS, Farrall M, et al; IBC 50K CAD Consortium: Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 7: e1002260, 2011.
18. Peden JF, Hopewell JC, Saleheen D, et al; Coronary Artery Disease (C4D) Genetics Consortium: A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 43: 339-344, 2011.
19. Higgs ZC, Macafee DA, Braithwaite BD and Maxwell-Armstrong CA: The Seldinger technique: 50 years on. Lancet 366: 1407-1409, 2005.
20. Reilly MP, Li M, He J, et al: Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 377: 383-392, 2011.
21. Gabriel S, Ziaugra L and Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter 2, Unit 2: 12, 2009.
22. Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003. (Pubitemid 37088507)
23. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997. (Pubitemid 27387172)
24. Excoffier L and Lischer HE: Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10: 564-567, 2010.
25. Dupont WD and Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials 11: 116-128, 1990. (Pubitemid 20136185)
26. Emslie C: Women, men and coronary heart disease: a review of the qualitative literature. J Adv Nurs 51: 382-395, 2005.
27. Robinson JG, Wang S and Jacobson TA: Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol 110: 1468-1476, 2012.
28. Li S, Lei ZW, Chen Z, et al: Relationship between apolipoprotein E and apolipoprotein B polymorphisms in youths with coronary heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20: 241-243, 2003 (In Chinese). (Pubitemid 36717968)
29. Huang G, Zhong H, Re HM, et al: Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks. J Geriatr Cardiol 9: 33-37, 2012.
30. Boffa MB, Marcovina SM and Koschinsky ML: Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin Biochem 37: 333-343, 2004. (Pubitemid 38490450)
31. Kamstrup PR: Lipoprotein(a) and ischemic heart disease - a causal association? A review. Atherosclerosis 211: 15-23, 2010.
32. Rath M, Niendorf A, Reblin T, et al: Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9: 579-592, 1989. (Pubitemid 19236892)
33. Kiechl S and Willeit J: The mysteries of lipoprotein(a) and cardiovascular disease revisited. J Am Coll Cardiol 55: 2168-2170, 2010.
34. Clarke R, Peden JF, Hopewell JC, et al; PROCARDIS Consortium: Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361: 2518-2528, 2009.
35. Chasman DI, Shiffman D, Zee RY, et al: Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 203: 371-376, 2009.
36. Luke MM, Kane JP, Liu DM, et al: A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 27: 2030-2036, 2007. (Pubitemid 47312314)
37. Schunkert H, König IR, Kathiresan S, et al: Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338, 2011.
38. Anderson RA and Sando GN: Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J Biol Chem 266: 22479-22484, 1991. (Pubitemid 21908678)
39. Anderson RA, Rao N, Byrum RS, et al: In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3. Genomics 15: 245-247, 1993. (Pubitemid 23079613)
40. Zschenker O, Illies T and Ameis D: Overexpression of lysosomal acid lipase and other proteins in atherosclerosis. J Biochem 140: 23-38, 2006. (Pubitemid 44433542)
41. Klima H, Ullrich K, Aslanidis C, et al: A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest 92: 2713-2718, 1993. (Pubitemid 24006536)